Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) - Total assets
Total assets on the balance sheet as of September 2023 : $0.53 B
According to Invitae 's latest financial reports the company's total assets are $0.53 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Invitae - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $1.95 B | -60.28% |
| 2021-12-31 | $4.91 B | 43.41% |
| 2020-12-31 | $3.43 B | 338.9% |
| 2019-12-31 | $0.78 B | 176.22% |
| 2018-12-31 | $0.28 B | 34.05% |
| 2017-12-31 | $0.21 B | 61.56% |
| 2016-12-31 | $0.13 B | -16.61% |
| 2015-12-31 | $0.15 B | 21.66% |
| 2014-12-31 | $0.12 B | 142.51% |
| 2013-12-31 | $53.1 M | 104.45% |
| 2012-12-31 | $25.97 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | $0.46 B | -12.99% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $10.86 M | -97.97% | 🇺🇸 USA |
 CareDx CDNA | $0.46 B | -12.76% | 🇺🇸 USA |